UltraNuclease is a nonspecific endonuclease derived from Serratia marcescens, also known as a nonrestrictive or broad-spectrum nuclease. It cleaves internal phosphodiester bonds to completely digest nucleic acids into 5′-monophosphate oligonucleotides 2-5 bases long. The enzyme degrades DNA and RNA in a wide range of forms, including double-stranded, single-stranded, linear, circular, native, and denatured nucleic acids. It is active under diverse conditions (6 M urea, 0.1 M guanidine HCl, 0.4% Triton X-100, 0.1% SDS, 1 mM EDTA, and 1 mM PMSF) and is widely used to remove nucleic acids from biological products. This genetically engineered enzyme is expressed in Escherichia coli (E. coli), purified, and purified in an ISO 13485-certified facility following strict GMP principles. In research applications, it reduces the viscosity of cell culture supernatants and cell lysates, improves protein purification efficiency, and supports functional studies. It is also used to remove residual host nucleic acids during virus purification, vaccine production, and the manufacture of protein and polysaccharide pharmaceuticals. Residual host nucleic acids can be reduced to picogram (pg) levels to improve the efficacy and safety of biological products. The enzyme also effectively prevents clumping of human peripheral blood mononuclear cells (PBMCs) in cell therapy and vaccine research. The product is supplied as a sterile, clear, colorless liquid enzyme in storage buffer containing 20 mM Tris-HCl (pH 8.0), 2 mM MgCl₂, 20 mM NaCl, and 50% glycerol. Features Wide range of applications: degrade all forms of DNA and RNA High purity and activity: purity ≥ 99%; specific activity ≥ 1.5×106 U/mg Strong adaptability: strong tolerance, adapt to a variety of reaction conditions Comply with pharmacopeia: no animal origin; no antibiotics; lower endotoxin Qualification: product gets the FDA DMF filling which can shorten the customers for new drug application GMP-grade manufacturing: strict standards to meet the needs of large-scale use for research to manufacture Application Purification of viral vaccines, viral vectors for the vaccine, and oncolytic viruses, removing DNA/RNA from proteins and other biologicals Reduction of viscosity caused by nucleic acids Sample preparation in electrophoresis and chromatography Prevention of cell clumping Specification Expression Host Recombinant E. coli with UltraNuclease gene Molecular Weight 26.5 kDa Isoelectric point 6.85 Purity ≥ 99% (SDS-PAGE) Storage Buffer 20 mM Tris-HCl pH8.0, 2 mM MgCl2, 20 mM NaCl, 50% glycerin Unit Definition The definition of one Activity unit (U) is the amount of enzyme used to change the absorption value of △A260 by 1.0 in 30 minutes in a 2.625 mL reaction system at 37°C with a pH of 8.0 (equivalent to complete digestion of 37 μg salmon sperm DNA into oligonucleotides). Components Components No. Name 20157ES25 (25 KU) 20157ES50 (50 KU) 20157ES60 (100 KU) 20157ES80 (1 MU) 20157ES90 (5 MU) 20157 UltraNuclease GMP-grade (250 U/μL) 100 μL 200 μL 400 μL 4 mL 20 mL Figures Quality No. Test Items Competitor Yeasen 1 Source E. coli E. coli 2 Activity ≥ 250 units/μL 250-300 units/μL 3 Specific Activity ≥1.1×106 U/mg ≥1.5×106 U/mg 4 Purity ≥ 99%(SDS) ≥ 99%(HPLC) 5 Endotoxin < 0.25EU/1000U < 0.25EU/1000U 6 Protease None Detected None Detected UltraNuclease Enzymatic Activity Under Different Conditions Temperature & pH Figure 1. Effects of temperature and pH on enzyme activity. (A) Enzyme activity increases with temperature, with the optimum at 37 °C. (B) The enzyme is active within pH 4–10, with pH 8.0 as the optimum. Salt ion concentration Figure 2. Effects of salt ion concentration on enzyme activity. (A). Na⁺/K⁺ inhibit enzyme activity; activity is completely lost above 300 mM, while good activity is retained below 20 mM. (B). Maximum activity is observed with 5 mM Mg²⁺; in the absence of Mg²⁺, 1–2 mM Mn²⁺ can support activity. (C). Increasing PO₄³⁻ concentration significantly inhibits enzyme activity. Surfactants Figure 3. Effects of surfactants on enzyme activity. (A) Triton® X-100 and (B) sodium deoxycholate reduce enzyme activity and should be maintained at low concentrations. Protein denaturants Figure 4. Effect of protein denaturants on enzyme activity. SDS and urea reduce enzyme activity and should be maintained at low concentrations. Other commonly used reagents Figure 5. Effects of different inhibitors on UltraNuclease activity. (A). Enzyme activity is strongly influenced by ammonium sulfate concentration. (B). PMSF shows little effect on enzyme activity. (C). At low EDTA concentrations (≤0.5 mM), enzyme activity is largely unaffected, whereas at 5 mM EDTA, activity is completely inhibited. Robust Performance Figure 6. Single-factor test comparison with Supplier M*. No significant difference was observed between Yeasen UltraNuclease and supplier M*. Strong stability Figure 7. Stability of UltraNuclease. (A) Enzyme activity remained unchanged after 4 weeks of storage at –20 °C and 4 °C, and after 2 weeks at 37 °C. (B) Enzyme activity was unaffected after 10 freeze–thaw cycles between –80 °C and –25 °C. Reaction conditions recommend Table 1. The optimal reaction conditions for UCF.ME™ UltraNuclease Factor Optimum Condition Effective condition Mg2+ 1-5mM 0-10mM pH 8-9 6-10 Temperature 37℃ 0-42℃ Na+/K+ 0-20mM 0-150mM PO43+ 0-10mM 0-100mM EDTA 0-0.5mM 0-5mM Triton®X-100 0%-0.4% 0%-1%